All of them need Fortecortin as part to their treatment. Thanks to you, they received their medication.
Igor Bondarenko is 4 y.o. and he was diagnosed with neuroblastoma in February 2022.
As you might know MIGB, that is radioactive Iodine, is an important part of this type of treatment. In most cases, neuroblastoma cells are capable of accumulating this radioisotope. And it turns out that these cells are, as it were, irradiated "from the inside", while the rest of the body suffers relatively little. After a few days, most of the radioactive isotope decays or is excreted from the body, and you can proceed to other stages of treatment. And our donors helped to get Iodine for both treatments.
Thanks to you Igor received this treatment and then got a bone-marrow transplant. We wish Igor a speedy and easy recovery.
Also with your support, we paid for the same therapy for Mariam Mukhtarova. But she didn’t win this battle, and left us on August 22, 2022.
Arina (8 yo), Katya (2 yo), and Kirill (9 yo) are diagnosed with Non Hodgkin's and Artem (4 yo) is suffering from ALL.
All of them need Fasturtec during their treatment. Fasturtec (Rasburicase injection) is used to treat high levels of uric acid (a natural substance that builds up in the blood as tumors break down) in people with certain types of cancer who are being treated with chemotherapy medications.
Thanks to you all kids received this medication.
“Roma is three and a half years old and from Vologda. Maxim is five years old, from a small town in Bashkortostan. But for doctors at the Dima Rogachev Children's Hematology Center, their stories are very similar. Both children have a very severe genetic disease, which affects only boys and dramatically impairs the function of the hematopoietic and immune systems. Wiskott-Aldrich syndrome entails dramatic deterioration of blood clotting, reduce resistance to infections, and produce a high risk of malignant tumors. Normal full life with this disease is only possible after a bone marrow transplant from a healthy donor: in this case, transplantation replaces the hematopoietic and immune systems with a donor's cells. But transplantation is a difficult and aggressive treatment. And during the period when the child is recovering from the introduction of donor cells, severe infectious and immune problems are possible, associated already with the consequences of the transplant itself. Sometimes these problems are of a very persistent nature, lasting many months or even years.”
Now Roma needs another treatment with Foscavir and Cidofovir. Thanks to you, we bought these medications.
UDT (07/03/2022) Unfortunately, Roma lost the battle, may he rest in peace.
This cancer commonly requires chemotherapy, but Kirill’s case is different. A standard treatment did not help, and Kirill had a relapse in March 2020.
The only chance for Kirill was a bone marrow transplant. After the first sadly unsuccessful attempt, the second transplant was performed just few days ago. Kirill is now recovering from this physically draining procedure and faced another life-threatening challenge, which is a serious post-transplant complication affecting Kirill’s liver called hepatic veno-occlusive disease. Then he needed a course of Defitelio. Our sister charity “Gift of Life” raised funds to pay for it in November 2021. And since then among other treatment Kirill needs Foscavir and this medication we managed to buy with your help.
David is 7 y.o. and he was diagnosed with neuroblastoma last August.
Starting from March David has been receiving MIGB-therapy, thanks to you.
Radioactive Iodine is an important part of this type of treatment. In most cases, neuroblastoma cells are capable of accumulating this radioisotope. And it turns out that these cells are, as it were, irradiated "from the inside", while the rest of the body suffers relatively little. After a few days, most of the radioactive isotope decays or is excreted from the body, and you can proceed to other stages of treatment. And our donors helped to get Iodine for both treatments.
Victor with acute myeloid leukemia needed Xospata, antitumor drug, and we were able to provide it.
“The efficiency of Xospata was studied in a clinical trial of 138 patients with relapsed or refractory AML having a confirmed FLT3 mutation. Twenty-one percent of patients achieved complete remission (no evidence of disease and full recovery of blood counts) or complete remission with partial hematologic recovery (no evidence of disease and partial recovery of blood counts) with treatment. Of the 106 patients who required red blood cell or platelet transfusions at the start of treatment with Xospata, 31 percent became transfusion-free for at least 56 days.” - says FDA.
Also you helped Alina to get Idarubicin and Ixoten.